<code id='1F9B081BCB'></code><style id='1F9B081BCB'></style>
    • <acronym id='1F9B081BCB'></acronym>
      <center id='1F9B081BCB'><center id='1F9B081BCB'><tfoot id='1F9B081BCB'></tfoot></center><abbr id='1F9B081BCB'><dir id='1F9B081BCB'><tfoot id='1F9B081BCB'></tfoot><noframes id='1F9B081BCB'>

    • <optgroup id='1F9B081BCB'><strike id='1F9B081BCB'><sup id='1F9B081BCB'></sup></strike><code id='1F9B081BCB'></code></optgroup>
        1. <b id='1F9B081BCB'><label id='1F9B081BCB'><select id='1F9B081BCB'><dt id='1F9B081BCB'><span id='1F9B081BCB'></span></dt></select></label></b><u id='1F9B081BCB'></u>
          <i id='1F9B081BCB'><strike id='1F9B081BCB'><tt id='1F9B081BCB'><pre id='1F9B081BCB'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:37
          Blue numbers and letter falling down a tunnel. -- health tech coverage from STAT
          Adobe

          A growing number of AI tools are being used to predict everything from sepsis to strokes, with the hope of accelerating the delivery of life-saving care. But over time, new research suggests, these predictive models can become a victim of their own success — sending their performance into a nosedive and generating inaccurate, potentially harmful results.

          “There is no accounting for this when your models are being tested,” said Akhil Vaid, an instructor of data-driven and digital medicine at the Icahn School of Medicine at Mount Sinai and author of the new research, published Monday in the Annals of Internal Medicine. “You can’t run validation studies, do external validation, run clinical trials — because all they’ll tell you is that the model works. And when it starts to work, that is when the problems will arise.”

          advertisement

          Vaid and his Mount Sinai colleagues simulated the deployment of two models that predicted a patient’s risk of dying and acute kidney injury within five days of entering the ICU. Their simulations assumed that the models did what they were supposed to — lower deaths and kidney injury by identifying patients for earlier intervention.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Medicare drug price negotiation program allowed for now
          Medicare drug price negotiation program allowed for now

          AfederaljudgemadeakeyrulinginalawsuitchallenginganewdrugpricingprogramAdobeWASHINGTON—Afederalcourtj

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Cigna to pay $172 million to settle Medicare Advantage fraud probe

          JuliaRendleman/GettyImagesforEventiveMarketingHealthinsurerCignaispayingmorethan$172milliontosettlea